David Niewolny
David Niewolny is the director of business development for healthcare/medical at NVIDIA, where he is focused on easing the adoption of AI in healthcare and medical applications. David has 18 years of experience building and leading healthcare-focused businesses within AWS, Real Time Innovations, NXP and Freescale Semiconductor. He is considered an industry authority on the use of new technology (wireless, cloud, IoT, artificial intelligence) in healthcare and medical applications. David holds an MBA from the University of Texas at Austin and a B.S. in biomedical/biochemical engineering from Iowa State University.
Siemens Healthineers Adopts MONAI Deploy for Medical Imaging AI
3.6 billion. That’s about how many medical imaging tests are performed annually worldwide to diagnose, monitor and treat various conditions. Speeding up the processing and evaluation of all these X-rays,… Read Article
Boom in AI-Enabled Medical Devices Transforms Healthcare
The future of healthcare is software-defined and AI-enabled. Around 700 FDA-cleared, AI-enabled medical devices are now on the market — more than 10x the number available in 2020. Many of… Read Article
Johnson & Johnson MedTech Works With NVIDIA to Broaden AI’s Reach in Surgery
AI — already used to connect, analyze and offer predictions based on operating room data — will be critical to the future of surgery, boosting operating room efficiency and clinical… Read Article
MAP Once, Run Anywhere: MONAI Introduces Framework for Deploying Medical Imaging AI Apps
Delivering AI-accelerated healthcare at scale will take thousands of neural networks working together to cover the breadth of human physiology, diseases and even hospital operations — a significant challenge in… Read Article
What Is a Smart Hospital?
Smart hospitals — which utilize data and AI insights to facilitate decision-making at each stage of the patient experience — can provide medical professionals with insights that enable better and… Read Article
NVIDIA AI Enterprise Helps Researchers, Hospitals Targeting Cancer Hit the Mark
Whether facilitating cancer screenings, cutting down on false positives, or improving tumor identification and treatment planning, AI is a powerful agent for healthcare innovation and acceleration. Yet, despite its promise,… Read Article